Synthesis and characterization of linked Eu(II)-containing complexes and paramagnetic shift reagents for hypoxia imaging
用于缺氧成像的含铕 (II) 连接络合物和顺磁位移试剂的合成和表征
基本信息
- 批准号:10241300
- 负责人:
- 金额:$ 2.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-01-18
- 项目状态:已结题
- 来源:
- 关键词:AcademiaBiologicalBreast CarcinomaChemicalsChemistryChemoresistanceChemotherapy and/or radiationClinicalClinical ResearchComplexContrast MediaDevelopmentDiagnosisDiagnosticEarly DiagnosisElectron Spin Resonance SpectroscopyEnvironmentEquipmentEuropiumFellowshipGoalsHealthHomeostasisHumanHypoxiaImageInternationalInvestmentsKnowledgeLigandsLinkLongevityMagnetic Resonance ImagingMalignant NeoplasmsMass Spectrum AnalysisMeasurementMedicineMetalsMethodsMissionMonitorMultimodal ImagingNMR SpectroscopyNeoplasm MetastasisOrganic SynthesisOutcomeOxidation-ReductionOxidesOxygenProtonsPublic HealthRadiation therapyReagentReportingResearchResearch Project GrantsResistanceSignal TransductionSurvival RateSynthesis ChemistrySystemTechniquesTrainingUnited States National Institutes of HealthUniversitiesWaterbasecareercontrast enhanceddesignimaging agentimaging modalityimprovedin vivoinnovationinstrumentationmeetingsmultimodalitynon-invasive imagingoxidationpreclinical studyradiation resistanceresponseresponsible research conductskillstherapy developmenttherapy outcometumortumor progression
项目摘要
There is a great need to study disruptions to redox and oxygen homeostasis in cancer because the presence of
hypoxic cores in tumors have been correlated to chemotherapy and radiation therapy resistance, metastases,
and overall cancer longevity. The long-term goal of the research project is to develop redox-responsive probes
that target unmet needs in the study of hypoxia in cancer. The overall objectives of this research project are (1)
to synthesize and characterize two EuII-containing probes tethered to a paramagnetic shift agent and (2) to study
the potential of these probes for use in redox-responsive multi-modal imaging using both relaxivity
measurements and paramagnetic-shift enhancement. The rationale that underpins the proposed research is that
the T1-weighted signal will only be present when EuII is in reducing environments, and the paramagnetic signal
will only be present once EuII is oxidized to EuIII in oxidizing environments, thus rendering the agent redox-
responsive for both imaging modalities. The expected outcome of this proposal is the successful synthesis and
characterization of two imaging agents that differ in Eu coordination environments. This outcome is expected to
have a positive impact because there is a critical need for new redox-responsive probes. The objectives of the
proposal are expected to be achieved by pursuing two specific aims: (1) to synthesize and characterize a EuII-
containing cryptate linked to a DyIII-containing paramagnetic-shift agent and (2) to synthesize and characterize
a EuII-containing tetraamide glycinate complex linked to a DyIII-containing paramagnetic-shift agent. The resulting
new complexes will be significant because they are expected to enable monitoring of changes in redox
environments resulting from therapies, consequently aiding in treatment development and selection as well as
increasing the basic understanding of the relationship between redox homeostasis and human health.
Furthermore, because redox homeostasis is relevant to the diagnosis, mechanistic understanding, and
therapeutic outcome of cancer, this proposal is expected to maximize returns in many other investments of the
NIH and is specifically pertinent to the NCI’s mission.
The proposed research project was designed to aid Corbin in developing her skillset in synthetic chemistry to
best prepare her for an independent career in academia, which is a significant goal of the fellowship training
plan. The Allen Research Group in the Chemistry Department at Wayne State University is the perfect
environment for this research because it is collaborative, innovative, and set up with all the equipment Corbin
will need to complete her research, including state-of-the-art instrumentation. In addition to the proposed
research project, the training plan also includes professional development opportunities, training in the
responsible conduct of research, and attending international scientific meetings.
由于存在
肿瘤中的低氧核心与化学疗法和放射治疗的耐药性,转移,
和整体癌症寿命。研究项目的长期目标是制定氧化还原响应性问题
该目标在研究癌症缺氧的研究中未满足的需求。该研究项目的总体目标是(1)
综合并表征两个含EUII的问题,这些问题系在一起到顺磁性转移剂和(2)
这些问题在氧化还原响应的多模式成像中使用的潜力都使用了两种松弛性
测量和顺磁性换档增强。拟议研究的基础的理由是
T1加权信号只有在EUII处于还原环境中,而Parmagnetic Signal才会存在
只有在氧化环境中将EUII氧化为EUIII,才会出现,从而使试剂氧化还原
对两种成像方式的反应。该提案的预期结果是成功的综合和
在欧盟协调环境中不同的两个成像剂的表征。这种结果有望
有积极的影响,因为对新的氧化还原响应问题有迫切需要。目标的目标
预计将通过追求两个具体目标来实现建议:(1)合成和表征EUII-
含有与含Dyiii的含氧磁磁性转移剂链接的隐质,(2)合成和表征
含EUII的四酰胺乙二醇化合物复合物与含DyiII的顺磁性移位剂相关。结果
新的复合物将很重要,因为它们有望能够监视氧化还原的变化
疗法产生的环境,因此有助于治疗开发和选择以及
增加对氧化还原稳态与人类健康之间关系的基本了解。
此外,因为氧化还原稳态与诊断,机械理解和
癌症的治疗结果,预计该建议将在许多其他投资中最大化回报
NIH,特别与NCI的使命有关。
拟议的研究项目旨在帮助Corbin发展合成化学方面的技能
最好的准备她为学术界的独立职业做好准备,这是奖学金培训的重要目标
计划。韦恩州立大学化学系的艾伦研究小组是完美的
这项研究的环境是因为它是协作,创新的,并且与所有设备Corbin建立
将需要完成她的研究,包括最先进的仪器。除了提议
研究项目,培训计划还包括专业发展机会,培训
负责任的研究进行,并参加国际科学会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brooke Anne Corbin其他文献
Brooke Anne Corbin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于3D生物打印类器官模型探究PAK5调控三阴性乳腺癌铂类耐药的机制研究
- 批准号:82303979
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤微环境响应的生物正交反应介导基因编辑系统用于三阴性乳腺癌的治疗
- 批准号:22377055
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肿瘤刚度调控乳腺癌发展的生物正交近红外在体可视化研究
- 批准号:32371433
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ADAR1通过调控核糖体生物合成促进HER2阳性乳腺癌耐药的机制研究
- 批准号:82373357
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于生物正交的单细胞组学探讨乳腺癌肿瘤微环境mRNA通讯机制
- 批准号:82303977
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms and In Vivo Efficacy of Synergistic Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia
酸性神经酰胺酶和 Bcl-2 协同抑制治疗急性髓系白血病的机制和体内疗效
- 批准号:
10743571 - 财政年份:2023
- 资助金额:
$ 2.09万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10701238 - 财政年份:2023
- 资助金额:
$ 2.09万 - 项目类别:
Developing corrector small molecules for reactivation of mutant p53 in cancer
开发用于重新激活癌症中突变 p53 的校正小分子
- 批准号:
10512976 - 财政年份:2022
- 资助金额:
$ 2.09万 - 项目类别:
Developing corrector small molecules for reactivation of mutant p53 in cancer
开发用于重新激活癌症中突变 p53 的校正小分子
- 批准号:
10675004 - 财政年份:2022
- 资助金额:
$ 2.09万 - 项目类别: